The body-on-a-chip concept: possibilities and limitations
暂无分享,去创建一个
[1] J. Kelm,et al. Multi-cell type human liver microtissues for hepatotoxicity testing , 2012, Archives of Toxicology.
[2] Adam S. Hayward,et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME , 2013, Archives of Toxicology.
[3] P. Bernardi,et al. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening , 2006, Archives of Toxicology.
[4] G. Damm,et al. Hepatic 3D cultures but not 2D cultures preserve specific transporter activity for acetaminophen-induced hepatotoxicity , 2013, Archives of Toxicology.
[5] M. L. Marquette,et al. A novel in vitro three-dimensional skeletal muscle model , 2007, In Vitro Cellular & Developmental Biology - Animal.
[6] Justin M. Weis,et al. Lung-on-a-chip microdevice, right ventricular dysfunction as a predictor of survival, and lung ultrasound in community-acquired pneumonia. , 2013, American journal of respiratory and critical care medicine.
[7] Michael R. Berthold,et al. From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects , 2014, Archives of Toxicology.
[8] Cheng-Hsien Liu,et al. A biologically inspired lung-on-a-chip device for the study of protein-induced lung inflammation. , 2015, Integrative biology : quantitative biosciences from nano to macro.
[9] E. Lock,et al. Transcriptomic alterations induced by Ochratoxin A in rat and human renal proximal tubular in vitro models and comparison to a rat in vivo model , 2011, Archives of Toxicology.
[10] I. Ilkavets. A special issue about hepatotoxicity and hepatocyte in vitro systems , 2013, Archives of Toxicology.
[11] B. Herpers,et al. A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies , 2014, Archives of Toxicology.
[12] Jiajie Yu,et al. On chip porous polymer membranes for integration of gastrointestinal tract epithelium with microfluidic ‘body-on-a-chip’ devices , 2012, Biomedical microdevices.
[13] T. Vanhaecke,et al. Simple and quick method for whole-liver decellularization: a novel in vitro three-dimensional bioengineering tool? , 2011, Archives of Toxicology.
[14] Andreas Hierlemann,et al. Reconfigurable microfluidic hanging drop network for multi-tissue interaction and analysis , 2014, Nature Communications.
[15] Robert Zweigerdt,et al. Your heart on a chip: iPSC-based modeling of Barth-syndrome-associated cardiomyopathy. , 2014, Cell stem cell.
[16] Jan G. Hengstler,et al. Pharmacokinetics explain in vivo/in vitro discrepancies of carcinogen-induced gene expression alterations in rat liver and cultivated hepatocytes , 2012, Archives of Toxicology.
[17] Hedi Peterson,et al. Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach , 2012, Archives of Toxicology.
[18] I. Wilson,et al. In vitro exploration of potential mechanisms of toxicity of the human hepatotoxic drug fenclozic acid , 2013, Archives of Toxicology.
[19] Josue A. Goss,et al. Microfluidic heart on a chip for higher throughput pharmacological studies. , 2013, Lab on a chip.
[20] H. Bolt. Developmental neurotoxicity testing with human embryonic stem cell-derived in vitro systems: the novel FP7 ESNATS tests are available , 2012, Archives of Toxicology.
[21] J. Hengstler,et al. Toxicokinetics of acrylamide in primary rat hepatocytes: coupling to glutathione is faster than conversion to glycidamide , 2013, Archives of Toxicology.
[22] D. Ingber,et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. , 2013, Integrative biology : quantitative biosciences from nano to macro.
[23] Paul Jennings,et al. Oxidative stress induced by potassium bromate exposure results in altered tight junction protein expression in renal proximal tubule cells , 2012, Archives of Toxicology.
[24] Jong Hwan Sung,et al. Using physiologically-based pharmacokinetic-guided “body-on-a-chip” systems to predict mammalian response to drug and chemical exposure , 2014, Experimental biology and medicine.
[25] J. G. Hengstler,et al. Profiling of drugs and environmental chemicals for functional impairment of neural crest migration in a novel stem cell-based test battery , 2014, Archives of Toxicology.
[26] M. Stern,et al. Human Ntera2 cells as a predictive in vitro test system for developmental neurotoxicity , 2013, Archives of Toxicology.
[27] J. Kelm,et al. Progress in ‘body-on-a-chip’ research , 2014, Archives of Toxicology.
[28] Sukhdeep Singh,et al. The future of the patient-specific Body-on-a-chip. , 2013, Lab on a chip.
[29] Jan Böttger,et al. Protocols for staining of bile canalicular and sinusoidal networks of human, mouse and pig livers, three-dimensional reconstruction and quantification of tissue microarchitecture by image processing and analysis , 2014, Archives of Toxicology.
[30] Dorit Merhof,et al. Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants , 2013, Archives of Toxicology.
[31] Kerong Dai,et al. Three-dimensional flow perfusion culture system for stem cell proliferation inside the critical-size beta-tricalcium phosphate scaffold. , 2006, Tissue engineering.
[32] Daniel C Leslie,et al. A Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice , 2012, Science Translational Medicine.
[33] Mandy B. Esch,et al. Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury. , 2014, Lab on a chip.
[34] J. Hengstler,et al. Primary rat hepatocytes as in vitro system for gene expression studies: comparison of sandwich, Matrigel and 2D cultures , 2008, Archives of Toxicology.
[35] T. Szekeres,et al. Inhibition of tumour spheroid-induced prometastatic intravasation gates in the lymph endothelial cell barrier by carbamazepine: drug testing in a 3D model , 2013, Archives of Toxicology.